Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAs
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 17, 2026
March 17, 2026
9120d697-9a7d-4aac-b9ff-98ee81aafa56
Related Documents
Pulmonary Tuberculosis: Developing Drugs for Treatment: Guidance for Industry
Guidance DocumentMay 8, 2026Center for Drug Evaluation and Research
Assessing Adhesion With Transdermal and Topical Delivery Systems for ANDAs: Guidance for Industry
Guidance DocumentJuly 31, 2026Center for Drug Evaluation and Research
Certain Postapproval Requirements and Resources for ANDAs
Guidance DocumentJune 4, 2026Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.